Molecular genetics & genomic medicine · 2020
Clinical aspects of Hyaline Fibromatosis Syndrome and identification of a novel mutation.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Härter Bettina, Benedicenti Francesco, Karall Daniela, Lausch Ekkehard, Schweigmann Gisela, Stanzial Franco, Superti-Furga Andrea, Scholl-Bürgi Sabine
Аннотация
BACKGROUND: Hyaline fibromatosis syndrome is an autosomal recessive disease caused by mutations in ANTXR2 which leads to loss of function of the transmembrane protein anthrax toxin receptor 2. It is distinguished by characteristic skin lesions, gingival hyperplasia, joint and bone disease, and systemic involvement.
METHODS: Based on the case of an 11-year-old female patient with typical features of hyaline fibromatosis syndrome and the underlying pathogenic compound heterozygote variants in ANTXR2 we discuss the genetic and clinical aspects of hyaline fibromatosis syndrome.
RESULTS: The novel mutation in ANTXR2 (c.1223T>C, p.Leu408Pro variant) seems to allow for a protracted course of the disease.
CONCLUSION: Our findings add to the phenotypic, genetic, and biochemical spectrum of hyaline fibromatosis syndrome.
METHODS: Based on the case of an 11-year-old female patient with typical features of hyaline fibromatosis syndrome and the underlying pathogenic compound heterozygote variants in ANTXR2 we discuss the genetic and clinical aspects of hyaline fibromatosis syndrome.
RESULTS: The novel mutation in ANTXR2 (c.1223T>C, p.Leu408Pro variant) seems to allow for a protracted course of the disease.
CONCLUSION: Our findings add to the phenotypic, genetic, and biochemical spectrum of hyaline fibromatosis syndrome.